★
GKOS
Glaukos Corp · Health Care
FCF-$18mF
Rev+36.3%A
D/E0.05A
P/S12.8xC
PEG——
63Score
$114.971Y Target$155.21Near-term target
5Y Target$231.25Compound horizon
10Y Target$601.73Long-dated conviction
FCF-$18mTTM · 03/26F
FCF is negative (-$18m) — cash-burning phase; acceptable only for pre-profit spec names · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+36.3%TTM YoYA
Revenue +36.3% — hypergrowth, top decile · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.05totalA
D/E 0.05 — essentially debt-free, pristine balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/S12.8xC
P/S 12.8x — elevated; requires growth to justify
PEG—proxy—
PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $6.8b. Down 22% from 52-week high of $148.11 — deep drawdown territory. Revenue growing +36% — in hypergrowth territory.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Free cash flow is negative (-$18m) — capital raises or debt issuance likely required; dilution / leverage risk. Currently unprofitable (margin -34.3%) — path to GAAP profitability is the core thesis risk. P/S 12.8x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Horizon
1-3 yr $155.21 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $231.25 — requires the platform / technology to reach commercial scale. 10 yr $601.73 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · GKOS
Shares to buy
17
Position size
$1,954
3.9% of portfolio
Stop price
$86.23
25% below $114.97
$ at risk
$500.00
1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.